Immunogenicity of a vaccine regimen composed of simian immunodeficiency virus DNA, rMVA, and viral particles administered to female rhesus macaques via four different mucosal routes
about
Induction of intestinal immunity by mucosal vaccines as a means of controlling HIV infectionChallenges in mucosal HIV vaccine development: lessons from non-human primate modelsVaccine-Elicited Mucosal and Systemic Antibody Responses Are Associated with Reduced Simian Immunodeficiency Viremia in Infant Rhesus MacaquesInduction of Potent and Long-Lived Antibody and Cellular Immune Responses in the Genitorectal Mucosa Could be the Critical Determinant of HIV Vaccine Efficacy.Comparative analysis of SIV-specific cellular immune responses induced by different vaccine platforms in rhesus macaquesHIV DNA Vaccine: Stepwise Improvements Make a Difference.Resistance to infection, early and persistent suppression of simian immunodeficiency virus SIVmac251 viremia, and significant reduction of tissue viral burden after mucosal vaccination in female rhesus macaquesRhesus macaque rectal and duodenal tissues exhibit B-cell sub-populations distinct from peripheral blood that continuously secrete antigen-specific IgA in short-term explant cultures.HIV vaccines: a brief overview.Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.DNA Vaccine-Induced Long-Lasting Cytotoxic T Cells Targeting Conserved Elements of Human Immunodeficiency Virus Gag Are Boosted Upon DNA or Recombinant Modified Vaccinia Ankara Vaccination
P2860
Q27001897-104E2926-CECB-4CA7-9B4D-6D3E1BE00FE8Q27022152-BFFB3C06-1C0A-48A5-99A1-FFF86612AB69Q28830298-2F089DDB-A53B-44BD-AA9C-D48E015E53DFQ33611645-DE2B037F-8029-4E87-9985-9C48D37576DDQ34616275-596C5D0D-BBF5-4210-83E8-B356050753DEQ35826742-42D582C8-9523-4247-BA34-FEDB0ECDF467Q37547763-34FB9836-EBA4-4DEB-8277-0253F6567146Q37564860-D13DA89F-064D-4ED5-81C1-6273B8F78B96Q38210557-47E38046-A608-43CD-A4B4-09EAC5E7AD8BQ40077472-D3E3073B-2701-4E42-BFBD-AB47651A24FFQ58711069-D651FC40-473A-4286-8DA3-2AA5C9A977AE
P2860
Immunogenicity of a vaccine regimen composed of simian immunodeficiency virus DNA, rMVA, and viral particles administered to female rhesus macaques via four different mucosal routes
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Immunogenicity of a vaccine re ...... four different mucosal routes
@ast
Immunogenicity of a vaccine re ...... four different mucosal routes
@en
type
label
Immunogenicity of a vaccine re ...... four different mucosal routes
@ast
Immunogenicity of a vaccine re ...... four different mucosal routes
@en
prefLabel
Immunogenicity of a vaccine re ...... four different mucosal routes
@ast
Immunogenicity of a vaccine re ...... four different mucosal routes
@en
P2093
P2860
P356
P1433
P1476
Immunogenicity of a vaccine re ...... four different mucosal routes
@en
P2093
Angela Carville
Anna Aldovini
Antonio Cobo-Molinos
Mariana Manrique
Pamela A Kozlowski
Robert L Wilson
Shainn-Wei Wang
P2860
P304
P356
10.1128/JVI.03531-12
P407
P577
2013-02-13T00:00:00Z